Vanda Pharmaceuticals (VNDA) Revenue Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3,790.58% |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | 3.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.35% |
| Dec 31, 2025 | 7.58% |
| Sep 30, 2025 | 18.06% |
| Jun 30, 2025 | 4.19% |
| Mar 31, 2025 | 5.43% |
| Dec 31, 2024 | 17.48% |
| Sep 30, 2024 | 22.76% |
| Jun 30, 2024 | 9.59% |
| Mar 31, 2024 | -24.06% |
| Dec 31, 2023 | -29.79% |
| Sep 30, 2023 | -40.58% |
| Jun 30, 2023 | -28.47% |
| Mar 31, 2023 | 3.83% |
| Dec 31, 2022 | -5.20% |
| Sep 30, 2022 | -6.82% |
| Jun 30, 2022 | -5.17% |
| Mar 31, 2022 | -3.95% |
| Dec 31, 2021 | 0.54% |
| Sep 30, 2021 | 16.23% |
| Jun 30, 2021 | 9.15% |
| Mar 31, 2021 | 8.05% |
| Dec 31, 2020 | 11.03% |
| Sep 30, 2020 | 1.38% |
| Jun 30, 2020 | 5.33% |
| Mar 31, 2020 | 21.56% |
| Dec 31, 2019 | 14.87% |
| Sep 30, 2019 | 21.06% |
| Jun 30, 2019 | 24.73% |
| Mar 31, 2019 | 9.45% |
| Dec 31, 2018 | 19.80% |
| Sep 30, 2018 | 18.87% |
| Jun 30, 2018 | 12.59% |
| Mar 31, 2018 | 16.51% |
| Dec 31, 2017 | 15.77% |
| Sep 30, 2017 | 7.42% |
| Jun 30, 2017 | 16.73% |
| Mar 31, 2017 | 12.49% |
| Dec 31, 2016 | 20.08% |
| Sep 30, 2016 | 35.77% |
| Jun 30, 2016 | 30.63% |
| Mar 31, 2016 | 50.17% |
| Dec 31, 2015 | 107.22% |
| Sep 30, 2015 | 91.75% |
| Jun 30, 2015 | 153.93% |
| Mar 31, 2015 | 142.26% |
| Dec 31, 2014 | 75.00% |
| Sep 30, 2014 | 69.73% |
| Jun 30, 2014 | 30.57% |
| Mar 31, 2014 | 13.32% |
| Dec 31, 2013 | 10.90% |
| Sep 30, 2013 | 5.08% |
| Jun 30, 2013 | -0.70% |
| Mar 31, 2013 | -0.90% |
| Dec 31, 2012 | -5.38% |
| Sep 30, 2012 | 4.00% |
| Jun 30, 2012 | 12.76% |
| Mar 31, 2012 | 8.53% |
| Dec 31, 2011 | 274.34% |
| Sep 30, 2011 | 9.98% |
| Jun 30, 2011 | 381.84% |